This trial is active, not recruiting.

Condition sciatica
Treatment far infrared radiation (5μm to 20μm wavelength)
Phase phase 1
Sponsor GAAD Medical Research Institute Inc.
Start date January 2006
End date March 2008
Trial size 2 participants
Trial identifier NCT00573807, GAAD-SCIA-CTP1


A preliminary study to determine the use of far infrared radiation for the treatment of back pain

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose treatment
far infrared radiation (5μm to 20μm wavelength)
Far Infrared Radiation (5μm to 20μm wavelength)for 30 to 40 minutes per treatment session.

Primary Outcomes

The primary end point is to determine the therapeutic effects of far infrared radiation on the Sciatic nerve.
time frame: 2 years and 6 months

Secondary Outcomes

Far infrared treatment for other pain syndromes
time frame: 2 years and 6 months

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Persons with lower back pain Exclusion Criteria: - None

Additional Information

Official title Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Sciatica.
Description Sciatica is created by joint misalignment, muscle spasm and inflammation. Generally, sciatica is a combination of lower back pain, pain radiating into the buttock and possibly down the leg. Far infrared radiation of the sciatic nerve, coupled with the stretching of the spinal cord, is a promising non-invasive method for treating sciatica.
Trial information was received from ClinicalTrials.gov and was last updated in January 2009.
Information provided to ClinicalTrials.gov by GAAD Medical Research Institute Inc..